当前位置:主页 > 医学论文 > 中医论文 >

四肢阴经刮疗配合针刺对乳腺增生病患者微循环血流灌注量的影响

发布时间:2018-06-21 20:27

  本文选题:乳腺增生病 + 微循环 ; 参考:《福建中医药大学》2016年硕士论文


【摘要】:目的:观察四肢阴经刮疗配合针刺对乳腺增生病(Hyperplastic disease of breast, HDB)的临床疗效及其对微循环血流灌注量的影响,探讨其可能的作用机制,以期为患者提供一种在日常生活里操作便捷、可自行护养又有一定疗效的方法。方法:本研究将48例HDB患者按1:1随机分为治疗组和对照组,治疗组采用四肢阴经刮疗配合针刺治疗,对照组单纯进行针刺治疗。运用乳腺彩超和激光多普勒血流仪检测,观察其治疗前、后的变化;同时于治疗前、后评定患者症状体征的积分,并进行统计数据分析。结果:1.治疗组和对照组疗程结束后的总有效率分别为95.83%和91.31%,总有效率经卡方检验,差异具有统计学意义(P0.05),说明治疗组疗效优于对照组。2.经过3个月经周期的治疗后,两组组内治疗前、后症状体征总积分、疼痛积分、肿块积分及伴随症状积分均有下降,且具有显著性差异(aP0.01),说明治疗组与对照组治疗HDB均有效果。3.经过3个月经周期的治疗后,治疗组、对照组的症状体征总积分分别为(17.44±7.77)分、(23.48±6.24)分,具有显著性差异(bP0.01);治疗组、对照组的疼痛积分分别为(7.25±2.49)分、(10.17±3.35)分,具有显著性差异(bP0.01);治疗组、对照组的伴随症状积分分别为(6.00±3.34)分、(8.61±3.16)分,具有显著性差异(bP0.01);而治疗后治疗组、对照组肿块积分分别为(4.19±4.53)分、(4.70±4.32)分,无显著性差异(cP0.05),说明治疗组对患者症状体征总积分、疼痛积分及伴随症状积分优于对照组,肿块积分与对照组无差异。4.经过3个月经周期的治疗后,与同组治疗前比较,治疗组在治疗后天池穴、神封穴和期门穴的血流量均升高,且均具有显著性差异( aP0.01);对照组在治疗后神封穴的血流量升高,且具有显著性差异(aP0.01),而天池穴与期门穴的血流量改变不明显,不具有显著性差异(bP0.05)。5.经过3个月经周期的治疗后,治疗组与对照组天池穴血流量分别为(68.52±27.00)PU、(50.41±30.09)PU,治疗组血流量升高优于对照组(cP0.01);治疗后,治疗组与对照组神封穴血流量分别为(69.82±22.07)PU、(48.23±29.18)PU,治疗组血流量升高优于对照组(cP0.01);治疗后,治疗组与对照组期门穴血流量分别为(58.30±24.83)PU、(42.24±15.82)PU,治疗组血流量升高优于对照组(cP0.01)结论:1.四肢阴经刮疗配合针刺治疗HDB的疗效优于单纯针刺。不仅可以缓解乳房疼痛,减轻肿块大小,且能改善全身伴随症状。2.四肢阴经刮疗配合针刺可加快血流速度,提高血流灌注量,改善乳腺的微循环障碍,这可能是本疗法对HDB治疗作用的主要机制。
[Abstract]:Objective: to observe the clinical effect and the effect on the blood flow perfusion of microcirculation of hyperplastic disease of breast, HDBs in patients with hyperplastic disease of breast, HDBs treated with curettage of Yin meridian of extremities, and to explore its possible mechanism, in order to provide a kind of convenient operation in daily life for patients. The method that can take care of oneself also has certain curative effect. Methods: 48 patients with HDB were randomly divided into treatment group and control group according to 1:1. The changes before and after treatment were observed by using mammary gland color Doppler ultrasonography and laser Doppler flow meter, and the scores of symptoms and signs of patients were evaluated before and after treatment, and the statistical data were analyzed. The result is 1: 1. The total effective rates of treatment group and control group were 95.83% and 91.31%, respectively. The total effective rate was significantly higher than that of control group by chi-square test, indicating that the curative effect of treatment group was better than that of control group. After three menstrual cycles, the total score of symptoms and signs, the score of pain, the score of mass and the score of accompanying symptoms were all decreased in the two groups before and after treatment, and the difference was significant (P 0.01), indicating that the treatment group and the control group were all effective in the treatment of HDB. After three menstrual cycles, the total scores of symptoms and signs in the treatment group and the control group were 23.48 卤6.24) and 10.17 卤3.35, respectively, and the pain scores in the treatment group were 7.25 卤2.49 and 10.17 卤3.35, respectively. In the treatment group, the scores of associated symptoms in the control group were 6.00 卤3.34 and 8.61 卤3.16, respectively, with significant difference between the two groups, while in the treatment group, the scores of mass in the control group were 4.19 卤4.53 and 4.70 卤4.32, respectively, indicating that there was no significant difference in the total score of symptoms and signs between the treatment group and the control group, indicating that the total scores of symptoms and signs of the patients in the treatment group were higher than those in the control group. The score of pain and associated symptoms was superior to that of the control group, and there was no difference between the mass score and the control group. 4. After three menstrual cycles, compared with the same group before treatment, the blood flow at Tianchi point, Shenfeng point and Shimen point in the treatment group increased after treatment, and there were significant differences (aP0.01), and the blood flow of Shenfeng acupoint in the control group was increased after treatment. There was no significant difference in blood flow between Tianchi acupoint and Zhimen acupoint, and there was no significant difference in blood flow between Tianchi acupoint and Zhimen acupoint, and there was no significant difference in blood flow between Tianchi acupoint and Zhimen acupoint. After three menstrual cycles, the blood flow at Tianchi point in the treatment group and the control group was 68.52 卤27.00 Pu (50.41 卤30.09) respectively, and the increase of blood flow in the treatment group was better than that in the control group (P 0.01). The blood flow at Shenfeng point in the treatment group and the control group was 48.23 卤29.18 渭 g / L respectively. The increase of blood flow in the treatment group was better than that in the control group (P 0.01), and after treatment, the blood flow at the portal point in the treatment group and the control group was 58.30 卤24.83 Pu (42.24 卤15.82), and the blood flow in the treatment group was higher than that in the control group (P 0.01). The curative effect of acupuncture combined with curettage of Yin meridian of extremities was better than that of simple acupuncture. Not only can alleviate the breast pain, reduce the size of the mass, and can improve the whole body associated symptoms. 2. 2. Combined with acupuncture and curettage of extremities yin meridian can accelerate blood flow speed, increase blood flow perfusion and improve microcirculation disturbance of mammary gland, which may be the main mechanism of this therapy in the treatment of HDB.
【学位授予单位】:福建中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R246.2

【相似文献】

相关期刊论文 前10条

1 张玉金,张文芝;乳腺增生病治疗体会[J];江苏中医;2000年07期

2 莫滚,李洪,谭俊;药物文胸治疗乳腺增生病868例[J];中国民族民间医药杂志;2000年05期

3 刘德林;乳增汤治疗乳腺增生病的临床体会[J];四川中医;2001年02期

4 彭清慧;中医周期辨证治疗乳腺增生病100例[J];四川中医;2001年10期

5 骆新莹;乳腺二胡汤治疗乳腺增生病48例[J];国医论坛;2001年01期

6 张景春,陈力;乳康汤内服外用治疗乳腺增生病2300例[J];河北中医;2001年09期

7 刘宝春;柴胡疏肝散加味治疗乳腺增生病1例[J];黑龙江中医药;2001年02期

8 司徒红林,任黎萍,陈前军;中医治疗乳腺增生病存在的问题与对策[J];中医药信息;2001年04期

9 张家花;女性乳腺增生病患者T,E_2,GH,PRL水平的临床意义[J];放射免疫学杂志;2002年03期

10 王苹;中医药对乳腺增生病研究的现状与展望[J];福建中医学院学报;2002年01期

相关会议论文 前10条

1 杨柳;姜萱;杨锦文;;生物波康乳仪治疗乳腺增生病68例观察[A];2007中华中医药学会外治分会第五次学会年会学术文集[C];2007年

2 夏仲元;伍锐敏;任卫华;庞洁;;理活丸治疗乳腺增生病的临床研究[A];2008年中医外科学术年会论文集[C];2008年

3 胡思源;宋阿凤;晋黎;;中药新药治疗乳腺增生病临床研究若干问题的探讨[A];第十一届全国中医及中西医结合乳腺病学术会议论文集[C];2009年

4 娄海波;;中医情志干预法治疗乳腺增生病42例[A];第十一届全国中医及中西医结合乳腺病学术会议论文集[C];2009年

5 裴晓华;郭琪;;乳腺增生未必为乳腺增生病[A];第十一届全国中医及中西医结合乳腺病学术会议论文集[C];2009年

6 申郑堂;刘少华;海健;;乳康宁治疗乳腺增生病112例临床分析[A];第一届全国中西医结合乳腺疾病学术会议论文汇编[C];2002年

7 娄海波;;中医情志干预法治疗乳腺增生病42例[A];第十二次全国中医、中西医结合乳房病学术会议论文集[C];2011年

8 刘晓雁;吴彦岚;司徒红林;刘鹏熙;;乳腺增生病中医临床诊疗方案专家咨询研究[A];第十二次全国中医、中西医结合乳房病学术会议论文集[C];2011年

9 郭璐;唐乾利;;乳腺增生病中医外治法研究进展[A];2008年中医外科学术年会论文集[C];2008年

10 宫少波;宋爱莉;;中医内治法治疗乳腺增生病的探讨[A];2008年中医外科学术年会论文集[C];2008年

相关重要报纸文章 前10条

1 燕正雄;中西医结合治疗乳腺增生病疗效观察[N];农村医药报(汉);2009年

2 上海中医药大学附属龙华医院 唐汉钧;乳腺增生病证治心得[N];中国中医药报;2009年

3 北京中医药大学第三附属医院 裴晓华;乳腺增生病的治疗[N];中国中医药报;2010年

4 王惟恒;乳腺增生病的中医外治法[N];中国中医药报;2002年

5 吴信受;乳腺增生病的中医治疗体会[N];中国中医药报;2003年

6 赵东;乳腺增生病的西药治疗[N];农村医药报(汉);2007年

7 ;中药内外合治乳腺增生病疗效满意[N];中国中医药报;2004年

8 上海中医药大学附属龙华医院终身教授、上海市名中医 唐汉钧;乳腺增生病的证治心得[N];上海中医药报;2009年

9 北京中医药大学第三附属医院 裴晓华;中医治疗乳腺增生病的优势[N];中国中医药报;2010年

10 四川 李翠祝;柴胡疏肝汤治乳腺增生病观察[N];民族医药报;2001年

相关博士学位论文 前6条

1 关兴;散瘀化痰综合脏腑调理乳腺增生病辨证论治优化方案的研究[D];山东中医药大学;2012年

2 李静蔚;乳腺增生病与血管生成因子表达的关系及中药干预作用的研究[D];山东中医药大学;2005年

3 孙二虎;丹仙片治疗乳腺增生病的实验研究[D];南京中医药大学;2009年

4 赵迎春;影像学在乳腺增生病痰瘀互结证疗效评价中的应用[D];山东中医药大学;2012年

5 张琼;乳腺增生病肝郁气滞证心理应激及内分泌的相关性研究[D];北京中医药大学;2006年

6 孙庆颖;乳腺增生病痰瘀互结证与中医体质、多普勒及钼靶影像学的相关性研究[D];山东中医药大学;2014年

相关硕士学位论文 前10条

1 李莎;乳腺增生病发病情况与中医证型相关性的研究[D];山东中医药大学;2012年

2 苏珊珊;中药疏肝散结、补肾柔肝周期疗法冶疗乳腺增生病的实验与临床研究[D];甘肃中医药大学(原名:甘肃中医学院);2015年

3 刘晓;散结消癖颗粒治疗肝郁痰凝型乳腺增生病的临床观察[D];山西省中医药研究院;2015年

4 陈泓宇;益气化痰散结法治疗乳腺增生病的临床观察[D];成都中医药大学;2015年

5 王超颖;乳腺增生病的中医全科治疗方法初探及乳康舒胶囊临床疗效评价研究[D];北京中医药大学;2016年

6 王海霞;中药外敷内服治疗乳腺增生病气滞血瘀型患者的临床疗效观察[D];新疆医科大学;2016年

7 张新均;推拿结合药物治疗肝郁痰凝型乳腺增生病的临床疗效观察[D];新疆医科大学;2016年

8 努尔曼古丽·卡马力;维吾尔医综合治疗异常黑胆质型乳腺增生病患者疗效观察研究[D];新疆医科大学;2016年

9 曾天宝;中医药治疗乳腺增生病的文献系统评价及中药用药规律分析[D];广州中医药大学;2016年

10 罗嘉仪;刮痧结合电针治疗肝郁气滞证乳腺增生病的临床研究[D];广州中医药大学;2016年



本文编号:2049907

资料下载
论文发表

本文链接:https://www.wllwen.com/zhongyixuelunwen/2049907.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户1a503***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com